| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 11 | 1 | 12 |
| Phenylethanolamine N-methyltransferase | 0 | 2 | 0 | 2 |
| Cytochrome P450 2A6 | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 11 | 1 | 12 |
| 5-hydroxytryptamine receptor 1A | 0 | 12 | 2 | 15 |
| Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 6 | 2 | 8 |
| 5-hydroxytryptamine receptor 1B | 0 | 10 | 1 | 11 |
| 5-hydroxytryptamine receptor 1D | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 1F | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 2B | 0 | 10 | 2 | 12 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 7 | 0 | 5 | 1 | 6 |
| 5-hydroxytryptamine receptor 5A | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 5B | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 3A | 0 | 3 | 1 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 1 | 3 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 4 |
| 5-hydroxytryptamine receptor 3B | 0 | 3 | 1 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 7 | 0 | 0 | 7 |
| phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
| NFKB1 protein, partial | 3 | 0 | 0 | 3 |
| GLS protein | 6 | 0 | 0 | 6 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 7 | 0 | 0 | 7 |
| cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
| chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
| muscarinic acetylcholine receptor M1 | 7 | 0 | 0 | 7 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Cytochrome P450 3A4 | 0 | 5 | 0 | 7 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 6 | 0 | 0 | 6 |
| vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
| ATP-binding cassette sub-family C member 3 | 0 | 9 | 0 | 9 |
| Multidrug resistance-associated protein 4 | 0 | 9 | 0 | 9 |
| Bile salt export pump | 0 | 11 | 0 | 11 |
| Translocator protein | 0 | 0 | 1 | 1 |
| Vasopressin V2 receptor | 0 | 3 | 2 | 6 |
| Oxytocin receptor | 0 | 1 | 2 | 3 |
| Vasopressin V1a receptor | 0 | 0 | 2 | 2 |
| Vasopressin V1a receptor | 0 | 3 | 3 | 6 |
| Vasopressin V1b receptor | 0 | 2 | 2 | 4 |
| Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 3 |
| Translocator protein | 0 | 2 | 0 | 3 |
| Oxytocin receptor | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 2 | 2 | 4 |
| Canalicular multispecific organic anion transporter 1 | 0 | 9 | 0 | 9 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
| 5-hydroxytryptamine receptor 3E | 0 | 3 | 0 | 3 |
| acetylcholinesterase | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
| RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
| SMAD family member 2 | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 3 | 0 | 0 | 3 |
| USP1 protein, partial | 4 | 0 | 0 | 4 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| SMAD family member 3 | 1 | 0 | 0 | 1 |
| TDP1 protein | 6 | 0 | 0 | 6 |
| GLI family zinc finger 3 | 6 | 0 | 0 | 6 |
| Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
| AR protein | 7 | 0 | 0 | 7 |
| estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 1, group I, member 3 | 7 | 0 | 0 | 7 |
| progesterone receptor | 4 | 0 | 0 | 4 |
| EWS/FLI fusion protein | 7 | 0 | 0 | 7 |
| glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
| retinoic acid nuclear receptor alpha variant 1 | 8 | 0 | 0 | 8 |
| retinoid X nuclear receptor alpha | 3 | 0 | 0 | 3 |
| estrogen-related nuclear receptor alpha | 8 | 0 | 0 | 8 |
| farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
| pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
| estrogen nuclear receptor alpha | 9 | 0 | 0 | 9 |
| G | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
| polyprotein | 3 | 0 | 0 | 3 |
| 67.9K protein | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
| nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
| geminin | 7 | 0 | 0 | 7 |
| histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
| 5-hydroxytryptamine receptor 3B | 0 | 3 | 0 | 3 |
| Interferon beta | 3 | 0 | 0 | 3 |
| HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
| Cellular tumor antigen p53 | 5 | 0 | 0 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 6 |
| 5-hydroxytryptamine receptor 1A | 0 | 6 | 5 | 11 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| D(2) dopamine receptor | 0 | 12 | 3 | 18 |
| Alpha-1B adrenergic receptor | 0 | 7 | 2 | 9 |
| Alpha-2C adrenergic receptor | 0 | 10 | 2 | 13 |
| D | 0 | 6 | 0 | 7 |
| Glutamate receptor 2 | 4 | 0 | 0 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 10 | 2 | 12 |
| D(1A) dopamine receptor | 0 | 11 | 1 | 13 |
| D(4) dopamine receptor | 0 | 7 | 1 | 11 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 3 |
| Alpha-1D adrenergic receptor | 0 | 7 | 2 | 9 |
| Alpha-1D adrenergic receptor | 0 | 9 | 1 | 11 |
| 5-hydroxytryptamine receptor 2A | 0 | 13 | 1 | 16 |
| 5-hydroxytryptamine receptor 2C | 0 | 12 | 2 | 14 |
| D(4) dopamine receptor | 0 | 4 | 0 | 4 |
| Histamine H1 receptor | 0 | 4 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 14 | 1 | 15 |
| 5-hydroxytryptamine receptor 7 | 0 | 5 | 1 | 6 |
| Alpha-1A adrenergic receptor | 0 | 7 | 2 | 10 |
| Histamine H1 receptor | 0 | 10 | 3 | 15 |
| Alpha-1B adrenergic receptor | 0 | 4 | 1 | 6 |
| D(3) dopamine receptor | 0 | 10 | 2 | 14 |
| 5-hydroxytryptamine receptor 2B | 0 | 11 | 2 | 13 |
| Alpha-1A adrenergic receptor | 0 | 8 | 2 | 10 |
| 5-hydroxytryptamine receptor 3A | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 6 | 0 | 10 | 1 | 12 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 4 | 0 | 4 |
| Spike glycoprotein | 6 | 0 | 1 | 7 |
| D(2) dopamine receptor | 0 | 10 | 2 | 14 |
| Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 9 | 0 | 9 |
| 5-hydroxytryptamine receptor 3D | 0 | 3 | 0 | 3 |
| Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3C | 0 | 3 | 0 | 3 |
| Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
| Histamine H3 receptor | 0 | 3 | 0 | 3 |
| cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
| D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
| Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
| Integrin alpha-5 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 2 |
| Cytochrome P450 2B6 | 0 | 0 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 3 |
| Sodium-dependent noradrenaline transporter | 0 | 9 | 1 | 10 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 2 | 0 | 3 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 7 | 1 | 8 |
| Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 2 | 0 | 4 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 4 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
| Luciferase | 4 | 0 | 0 | 4 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| Histone H2A.x | 4 | 0 | 0 | 4 |
| lamin isoform A-delta10 | 6 | 0 | 0 | 6 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| arylsulfatase A | 5 | 0 | 0 | 5 |
| Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
| cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 2 | 1 | 6 |
| GABA theta subunit | 3 | 2 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | 3 | 2 | 1 | 6 |
| ORF73 | 0 | 0 | 1 | 1 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
| caspase-3 | 3 | 0 | 0 | 3 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
| mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
| atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 10 | 0 | 10 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 5 | 0 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 7 | 2 | 9 |
| Muscarinic acetylcholine receptor M4 | 0 | 7 | 1 | 8 |
| Muscarinic acetylcholine receptor M5 | 0 | 7 | 0 | 7 |
| Alpha-2A adrenergic receptor | 0 | 9 | 2 | 12 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Cytochrome P450 2D6 | 0 | 4 | 0 | 6 |
| Muscarinic acetylcholine receptor M1 | 0 | 7 | 3 | 10 |
| Alpha-2B adrenergic receptor | 0 | 8 | 1 | 10 |
| Alpha-2B adrenergic receptor | 0 | 5 | 2 | 7 |
| Alpha-2C adrenergic receptor | 0 | 5 | 2 | 7 |
| Alpha-2A adrenergic receptor | 0 | 5 | 2 | 7 |
| Histamine H2 receptor | 0 | 6 | 0 | 6 |
| Trypanothione reductase | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 3 | 0 | 3 |
| Trypanothione reductase | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 2 | 1 | 0 | 3 |
| D(1A) dopamine receptor | 1 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| Proteasome subunit alpha type-6 | 0 | 0 | 1 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Envelope glycoprotein | 0 | 0 | 1 | 1 |
| Ataxin-2 | 4 | 0 | 0 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 5 | 0 | 5 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
| IDH1 | 1 | 0 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
| Bile salt export pump | 0 | 4 | 0 | 4 |
| Albumin | 0 | 0 | 2 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 4 | 0 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 3 | 0 | 4 |
| Angiotensin-converting enzyme | 0 | 5 | 0 | 5 |
| Beta-1 adrenergic receptor | 0 | 4 | 1 | 6 |
| D(3) dopamine receptor | 0 | 6 | 1 | 9 |
| D(2) dopamine receptor | 0 | 3 | 0 | 3 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 3 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 3 | 0 | 4 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Calmodulin | 0 | 0 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
| Transporter | 0 | 3 | 0 | 3 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 5 | 0 | 5 |
| Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
| D | 0 | 3 | 0 | 3 |
| ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
| Histamine H4 receptor | 0 | 1 | 1 | 2 |
| Transporter | 0 | 3 | 0 | 3 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 3 |
| Albumin | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 3 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 3 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 3 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 3 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 3 |
| Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| dopamine D1 receptor | 2 | 0 | 0 | 2 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| WRN | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 0 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 3 | 1 | 4 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
| Adenosine receptor A3 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| Adenosine receptor A2a | 0 | 1 | 2 | 3 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 1 | 2 |
| Delta-type opioid receptor | 0 | 1 | 1 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 0 | 1 | 1 |
| Dipeptidyl peptidase 4 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 1 | 2 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Smad3 | 1 | 0 | 0 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
| Guanine deaminase | 0 | 1 | 0 | 1 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| Histone deacetylase 3 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 2 | 0 | 2 |
| Histone deacetylase 1 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 2 | 0 | 2 |
| Histone deacetylase 2 | 0 | 2 | 0 | 2 |
| Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
| Histone deacetylase 11 | 0 | 2 | 0 | 2 |
| Histone deacetylase 8 | 0 | 2 | 0 | 2 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 2 | 0 | 2 |
| Histone deacetylase 9 | 0 | 2 | 0 | 2 |
| Histone deacetylase 5 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |